Which type of fluid to use perioperatively?

Ilonka N. de Keijzer, T. Kaufmann, T. Scheeren
{"title":"Which type of fluid to use perioperatively?","authors":"Ilonka N. de Keijzer, T. Kaufmann, T. Scheeren","doi":"10.21037/jeccm.2019.08.07","DOIUrl":null,"url":null,"abstract":"Fluid administration in the perioperative period is daily clinical practice for all anesthesiologists. The goal of fluid administration is to increase cardiac output in order to ultimately improve oxygen delivery to the tissues. Fluid therapy can be given as maintenance or as replacement fluid therapy. For both of these therapies balanced crystalloids belong to the first line of treatment. Colloids are used for fluid replacement as well, but are given for more specific indications such as hypovolemia as a consequence of blood loss. Fluids, as any other intravenous drug, have indications, contra-indications, and potential side-effects. No conclusive evidence exists over the way and amount of fluids that should be administered, and several strategies have been developed, e.g., restrictive or liberal fluid therapy or perioperative goal-directed therapy (PGDT). Restrictive fluid therapy uses limited amounts of fluid compared to liberal fluid therapy, however no clear definitions of restricted or liberal fluid therapy are available. PGDT uses hemodynamic variables to assess fluid responsiveness and to guide fluid therapy in order to optimize the hemodynamic status of the patient. Future directions in fluid administration are to use personalized hemodynamic target values and to use PGDT in closed-loop systems. Most important, fluids should be administered with the same caution that is used with any intravenous drug.","PeriodicalId":73727,"journal":{"name":"Journal of emergency and critical care medicine (Hong Kong, China)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/jeccm.2019.08.07","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of emergency and critical care medicine (Hong Kong, China)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/jeccm.2019.08.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Fluid administration in the perioperative period is daily clinical practice for all anesthesiologists. The goal of fluid administration is to increase cardiac output in order to ultimately improve oxygen delivery to the tissues. Fluid therapy can be given as maintenance or as replacement fluid therapy. For both of these therapies balanced crystalloids belong to the first line of treatment. Colloids are used for fluid replacement as well, but are given for more specific indications such as hypovolemia as a consequence of blood loss. Fluids, as any other intravenous drug, have indications, contra-indications, and potential side-effects. No conclusive evidence exists over the way and amount of fluids that should be administered, and several strategies have been developed, e.g., restrictive or liberal fluid therapy or perioperative goal-directed therapy (PGDT). Restrictive fluid therapy uses limited amounts of fluid compared to liberal fluid therapy, however no clear definitions of restricted or liberal fluid therapy are available. PGDT uses hemodynamic variables to assess fluid responsiveness and to guide fluid therapy in order to optimize the hemodynamic status of the patient. Future directions in fluid administration are to use personalized hemodynamic target values and to use PGDT in closed-loop systems. Most important, fluids should be administered with the same caution that is used with any intravenous drug.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
围手术期使用哪种液体?
围手术期给药是所有麻醉师的日常临床实践。液体给药的目的是增加心输出量,以最终改善向组织的氧气输送。液体治疗可以作为维持或替代液体治疗来给予。对于这两种疗法来说,平衡晶体属于第一道治疗线。胶体也用于液体置换,但用于更具体的适应症,如失血导致的低血容量。液体和任何其他静脉注射药物一样,有适应症、禁忌症和潜在的副作用。关于应该给予的液体的方式和数量,没有确凿的证据,已经制定了几种策略,例如限制性或自由性液体治疗或围手术期目标导向治疗(PGDT)。与自由液体疗法相比,限制性液体疗法使用有限量的液体,然而,限制性或自由性液体疗法没有明确的定义。PGDT使用血液动力学变量来评估液体反应性并指导液体治疗,以优化患者的血液动力学状态。流体给药的未来方向是使用个性化的血液动力学目标值,并在闭环系统中使用PGDT。最重要的是,液体的使用应与任何静脉注射药物一样谨慎。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.10
自引率
0.00%
发文量
0
期刊最新文献
Optimal management of mobile cabin hospitals during the COVID-19 pandemic: experience from Shanghai, China A case series of Slow continuous ultrafiltration for COVID-19 patients on extracorporeal membrane oxygenation Treatment of respiratory syncytial virus with palivizumab in an adult liver transplant recipient: a case report Pituitary apoplexy mimicking stroke and myocardial infarction: a case report Diagnosis, management and treatment of nosocomial pneumonia in ICU: a narrative review
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1